Structure

InChI Key DYLUUSLLRIQKOE-UHFFFAOYSA-N
Smile CC(C)(O)CNc1nc(Nc2ccnc(C(F)(F)F)c2)nc(-c2cccc(C(F)(F)F)n2)n1
InChI
InChI=1S/C19H17F6N7O/c1-17(2,33)9-27-15-30-14(11-4-3-5-12(29-11)18(20,21)22)31-16(32-15)28-10-6-7-26-13(8-10)19(23,24)25/h3-8,33H,9H2,1-2H3,(H2,26,27,28,30,31,32)

Physicochemical Descriptors

Property Name Value
Molecular Formula C19H17F6N7O
Molecular Weight 473.38
AlogP 4.29
Hydrogen Bond Acceptor 8.0
Hydrogen Bond Donor 3.0
Number of Rotational Bond 6.0
Polar Surface Area 108.74
Molecular species NEUTRAL
Aromatic Rings 3.0
Heavy Atoms 33.0

Pharmacology

Targets EC50(nM) IC50(nM) Kd(nM) Ki(nM) Inhibition(%)
Enzyme Oxidoreductase
- 9-1080 - - 11-57

Indications

Mesh Heading Maximum Phase Mesh ID Reference
Neoplasms 4 D009369 ClinicalTrials
Leukemia 3 D007938 ClinicalTrials
Myelodysplastic Syndromes 2 D009190 ClinicalTrials
Leukemia, Myeloid, Acute 2 D015470 ClinicalTrials
Leukemia, Myelomonocytic, Chronic 2 D015477 ClinicalTrials
Liver Diseases 1 D008107 ClinicalTrials
Hematologic Neoplasms 1 D019337 ClinicalTrials
Multiple Myeloma 1 D009101 ClinicalTrials

Related Entries

Salt

Cross References

Resources Reference
CAS NUMBER 1446502-11-9
ChEBI 145374
ChEMBL CHEMBL3989908
DrugBank DB13874
DrugCentral 5251
FDA SRS 3T1SS4E7AG
Guide to Pharmacology 8960
PDB 69Q
PubChem 89683805
SureChEMBL SCHEMBL15102202
ZINC ZINC000222731806